The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Published inEMBO molecular medicine, vol. 6, no. 10, p. 1263-1278
Publication date2014
Abstract
Citation (ISO format)
MELOTTI, Alice et al. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. In: EMBO molecular medicine, 2014, vol. 6, n° 10, p. 1263–1278. doi: 10.15252/emmm.201404084
Main files (1)
Article (Published version)
Identifiers
- PID : unige:44224
- DOI : 10.15252/emmm.201404084
- PMID : 25143352
ISSN of the journal1757-4676